SAI International Revenue and Competitors

USA

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • SAI International's estimated annual revenue is currently $22.4M per year.(i)
  • SAI International's estimated revenue per employee is $270,000

Employee Data

  • SAI International has 83 Employees.(i)
  • SAI International grew their employee count by 5% last year.

SAI International's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$354.2M9376%N/AN/A
#2
$4.5M24-14%N/AN/A
#3
$25.9M96-14%N/AN/A
#4
$18M74-16%N/AN/A
#5
$10.8M509%N/AN/A
#6
$32.9M1228%N/AN/A
#7
$187.3M5559%N/AN/A
#8
$417.7M110522%N/AN/A
#9
$25.9M9628%N/AN/A
#10
$108.7M3228%N/AN/A
Add Company

What Is SAI International?

SAI International believes that there is no one single magic bullet to prevent, or cure diabetes and its complications. The mission of SAI International is to assist and empower prediabetic and diabetic individuals struggling to manage their overall well-being, specifically blood glucose, HbA1C levels and complications. This is achieved by: Focused research in discovering bioavailable ingredients that act in synergy to prevent and manage diabetes. Conducting clinical studies to investigate the safety, tolerability and efficacy of such multi- functional ingredients. Providing latest scientific information and clinical developments in diabetes research and evidence based nutritional products. Lifestyle changes, combined with the science-based ingredients in SAI’s products empower prediabetic and diabetic individuals to take charge of their overall health. This allows them to prevent, delay, manage or even reverse prediabetes and type 2 diabetes and complications.

keywords:N/A

N/A

Total Funding

83

Number of Employees

$22.4M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.7M83-2%N/A
#2
$7.5M834%N/A
#3
$24.1M838%N/A
#4
$27.4M831%N/A
#5
$14.9M83-2%N/A